MiNK Therapeutics (INKT) CEO sells 6,938 shares solely to cover taxes owed upon vesting.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
MiNK Therapeutics CEO Jennifer Buell sold 6,938 common shares at a weighted average price of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context